The Weekly Bull Report – April 03, 2022 🗞

Welcome to the 195th edition of The Weekly Bull Report.

Biden’s policies will bring about a full-blown global recession. 🤔

The Russian Ruble is back to where it was before the war. 🤔

Markets will turn north as mid-term elections will be a blowout for Republicans. 🤔

Here’s a shortlist of the content we found interesting and informative over the past week…


🤔 Interesting Articles & News:

















💲 Noteworthy Stocks & Assets:


🚨 Investment Opportunity: Ridgeline Therapeutics 🔬

Brought to you by Longevity Technology:

Longevity.Technology is fundraising for Ridgeline Therapeutics, a US biotechnology company, that is on a mission to reverse age-related decline in muscle strength, which is linked to lower quality of life and increased morbidity. 💪

Ridgeline’s NNMTi is slated to be the first FDA-approved drug to reverse declines in muscle strength; it is protected by a strong IP portfolio and will be delivered as a daily pill to restore muscle strength and function in the elderly. NNMTi demonstrates superior characteristics compared to competing therapeutics. 👩‍🔬

Preclinical safety and efficacy data have significantly de-risked IND filing and there is a clear path for expansion of clinical indication and clinical development; a fast FDA approval strategy will be employed by the team. ☑️

The experienced leadership team of successful entrepreneurs and scientists has secured $8.95 million in grant funding.

➡️ Link to the deck ⬅️



Earnings spotlight:

Tuesday, April 5: Lindsay Corporation (LNN) and Acuity Brands (NYSE:AYI).

Wednesday, April 6: Greenbrier (GBX), Tilray (TLRY) and Levi Strauss (NYSE:LEVI).

Thursday, April 7: Constellation Brands (NYSE:STZ), ConAgra Brands (CAG), Lamb Weston (LW) and PriceSmart (PSMT).


IPOs expected to start trading this week:

IPO and SPAC watch: Allvue Systems Holdings (ALVU) and Allvue Systems Holdings (INTM) could start trading next week. IPO lockup expirations hit this week on Life Time Group (LTH), Theseus Pharmaceuticals (NASDAQ:THRX), Pyxis Oncology (NASDAQ:PYXS), Cognition Therapeutics (CGTX) and UTime (UTME).


🎯 Stocks On Our RaBiohaven Pharmaceutical (NYSE: BHVN) 📈 – $200 target 


🏆 Quotes That Inspire Us:

“I know they call a donkey a horse when they want to sell it and a horse a donkey when they want to buy.”

– Galileo Galilei.


📖 Word Of The Week:

Palatable | pa·luh·tuh·bl | adjective – can mean “agreeable to one’s sense of taste or palate” or “agreeable or acceptable to the mind.”

“The soup was too bland for my taste, so I added some salt and pepper to make it palatable.”

“Those who are afraid of flying often consider traveling by train as the palatable alternative.”


Did You Know:

The probability of a blue lobster existing is widely touted as being one in two million. Bright blue lobsters are so-colored because of a genetic abnormality that causes them to produce more of a certain protein than others. 🦞


📚 Books We Are Reading:


🤣 One-Liners:

Q: How do you find a small-cap fund manager?

A: Find a large-cap fund manager and wait.


📽 A Must Watch & Listen:


📆 Upcoming Events:

Decentralized Finance – Where Do We Grow From Here?
April 20, 2:00 PM – 3:00 PM CEST

> Register Here <



Our very best wishes for a brilliant upcoming week! 💪

Respectfully yours,

The IBR Team

Please send any news, comments, or stock ideas to and follow IBR on Twitter @IBullReport Resultado de imagen de twitter logo

All content provided by Internet Bull Report is for informational and educational purposes only and is not meant to represent trade or investment recommendations.


Spread the love
Contrarian's Mind

Born in Toronto Lived in Nassau, Bahamas - Palm Beach, Florida - Las Vegas, Nevada - Barcelona, Spain, and now residing in beautiful Cape Town, South Africa. I back bright entrepreneurs with big ideas related to Artificial Intelligence, Machine Learning, realtime platforms and price discovery. Make everyday remarkable!